FDA Fast-Tracks New Weight Loss Drug Foundayo Under Priority Program
Orforglipron approved 294 days ahead of schedule for obesity treatment, marking first drug under new priority voucher system.
Type 1 and type 2 diabetes, insulin resistance, glucose metabolism, and metabolic health
228 articles
Orforglipron approved 294 days ahead of schedule for obesity treatment, marking first drug under new priority voucher system.
Deep dive into the master regulatory pathways controlling mitochondrial biogenesis, quality control, and cellular energy homeostasis through PGC-1α coordination.
Deep dive into GLP-1 receptor mechanisms, cAMP-PKA signaling cascades, and their role in metabolic health and longevity pathways.
Discover how this powerful gut hormone controls hunger, blood sugar, and may hold keys to healthy aging.
Large study of 13,706 adults finds better glucose disposal rate significantly protects against stroke, especially in middle-aged participants.
Deep dive into sirtuin enzymatic mechanisms, substrate specificity, and their role in metabolic reprogramming through NAD+-dependent deacetylation cascades.
New research reveals how fat tissue communicates with the placenta during pregnancy complications.
24-week study finds no significant differences in bone turnover markers between dietary approaches in adolescents with diabetes.
Simple sugar supplement dramatically improved diabetes symptoms in mice by stopping inflammatory cells from releasing disease-causing particles.
Study of 8,446 pregnancies reveals how maternal glucose and triglyceride levels affect fetal growth patterns.
New study shows combining body roundness index with triglyceride-glucose index achieves 80% accuracy in predicting fatty liver disease.
8-year study of 3,505 Chinese adults shows combining triglyceride-glucose index with waist circumference best predicts cardiovascular disease.